Details for Patent: 9,259,421
Which drugs does patent 9,259,421 protect, and when does it expire?
Patent 9,259,421 protects ZUBSOLV and is included in one NDA.
This patent has fifty-one patent family members in thirty-two countries.
Summary for Patent: 9,259,421
| Title: | Abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| Abstract: | There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise a disintegrant and/or particles of a pharmacologically-effective amount of naloxone, or a pharmaceutically-acceptable salt thereof. The compositions are useful in the treatment of opioid dependency/addiction and/or pain. |
| Inventor(s): | Andreas Fischer |
| Assignee: | Edenbridge Pharmaceuticals LLC |
| Application Number: | US14/668,973 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,259,421 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 9,259,421
International Family Members for US Patent 9,259,421
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012311293 | ⤷ Start Trial | |||
| Australia | 2013245546 | ⤷ Start Trial | |||
| Brazil | 112014006356 | ⤷ Start Trial | |||
| Canada | 2834327 | ⤷ Start Trial | |||
| Chile | 2014000575 | ⤷ Start Trial | |||
| China | 103813785 | ⤷ Start Trial | |||
| Colombia | 6960541 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
